Global Digital Store – Ebooks and Softwares

Tag: Safe

COVID-19: IFRC, UNICEF and WHO issue guidance to protect children and support safe school operations
GENEVA/NEW YORK – The International Federation of the Red Cross (IFRC), UNICEF and the World Health Organization (WHO) today issued new guidance to help protect children and schools from transmission of the COVID-19 virus. The guidance provides critical considerations and practical checklists to keep schools safe. It also advises national and local authorities on how to adapt and implement emergency plans for educational facilities.

In the event of school closures, the guidance includes recommendations to mitigate against the possible negative impacts on children’s learning and wellbeing. This means having solid plans in place to ensure the continuity of learning, including remote learning options such as online education strategies and radio broadcasts of academic content, and access to essential services for all children. These plans should also include necessary steps for the eventual safe reopening of schools.

Where schools remain open, and to make sure that children and their families remain protected and informed, the guidance calls for:
- Providing children with information about how to protect themselves;
- Promoting best handwashing and hygiene practices and providing hygiene supplies;
- Cleaning and disinfecting school buildings, especially water and sanitation facilities; and
- Increasing airflow and ventilation.
The guidance, while specific to countries that have already confirmed the transmission of COVID-19, is still relevant in all other contexts. Education can encourage students to become advocates for disease prevention and control at home, in school, and in their community by talking to others about how to prevent the spread of viruses. Maintaining safe school operations or reopening schools after a closure, requires many considerations, but if done well, can promote public health.

For example, safe school guidelines implemented in Guinea, Liberia and Sierra Leone during the outbreak of Ebola virus disease from 2014 to 2016 helped prevent school-based transmissions of the virus.

UNICEF is urging schools – whether open or helping students through remote learning – to provide students with holistic support. Schools should provide children with vital information on handwashing and other measures to protect themselves and their families; facilitate mental health support; and help to prevent stigma and discrimination by encouraging students to be kind to each other and avoid stereotypes when talking about the virus.

The new guidance also offers helpful tips and checklists for parents and caregivers, as well as children and students themselves. These actions include:
- Monitoring children’s health and keeping them home from school if they are ill;
- Encouraging children to ask questions and express their concerns; and
- Coughing or sneezing into a tissue or your elbow and avoid touching your face, eyes, mouth and nose.
Read More
https://www.who.int/news-room/detail/10-03-2020-covid-19-ifrc-unicef-and-who-issue-guidance-to-protect-children-and-support-safe-school-operations

Views: 0
March 11, 2020
Building a nuclear plant? Go online

Bucking current trends toward safe, clean and renewable energy resources, a Silicon Valley entrepreneur last week launched an initiative to reignite enthusiasm for nuclear energy.

Read More

Views: 0

March 10, 2020
End in sight, but flare-ups likely in the Ebola outbreak in the Democratic Republic of the Congo
Remarks by Dr Ibrahima Socé Fall, World Health Organization Assistant Director-General, Emergency Response

Good afternoon.

I hope that your busy week was interrupted, like mine, with a moment of joy on Tuesday.

That moment was the celebration of a woman being discharged from an Ebola treatment centre in Beni. Her name is Masiko.

She was the last person in the Democratic Republic of the Congo confirmed to have Ebola.

Health workers and other responders sacrificed a lot to get to this point.

Since the outbreak was declared in August 2018 there have been 420 attacks on health facilities in DRC, resulting in 11 deaths and 86 injuries among health care workers and patients.

It’s been a huge amount of work. At the peak of the outbreak, more than 120 cases were being reported each week. 28 health zones were affected, with cases appearing 1200 kilometres apart. In response:
- 11 labs have been set up to test around 3500 samples each week
- 11 Ebola treatment centres were set up to care for people with Ebola
- 300 000 people have been vaccinated
- 250 000 contacts have been registered
- 26 000 safe and dignified burials have been conducted
- More than 3000 health facilities were identified for infection prevention and control support
- More than 1000 metric tonnes of supplies have been delivered
- An Ebola vaccine has been licensed, and two treatments found to be highly effective
- Almost 160 000 million people have been screened for Ebola symptoms at borders or other points of control
This work is continuing. The outbreak isn’t over. WHO recommends waiting two full incubation periods – that’s 42 days – after the last person tests negative a second time before declaring the end of the outbreak.

We must stay in active response mode to get us over that finish line.

We have to be prepared for other cases emerging. It’s is a very real risk.

Remember that during the Ebola outbreak in West Africa flare-ups of new cases occurred after the end of the outbreak.

There are four reasons why new cases may emerge during this 42-day period, or even after the end of the outbreak.
- First, because of the complex security environment, Ebola transmission outside of groups under monitoring is possible.
- Second, Ebola virus can persist in used needles, syringes or vials for several weeks.
- Third, Ebola virus can persist in the body fluids of survivors for many months, and can be transmitted well after recovery, or in rare cases can result in relapse – as we’ve already seen during this outbreak.
- Finally, Ebola virus is present in an animal reservoir in the region, and there is always a risk of a new spillover to humans.
This is why it’s critical to maintain surveillance and rapid response capacities.

And that’s what we are doing. We’re still in full response mode.

In addition to the activities I already mentioned, I have to underline how critical it is to continue supporting the Survivor Programme, which provides follow-up care for almost all of the 1169 survivors in 26 health areas in North Kivu and Ituri. The programme also helps reduce the risks of re-introduction events.

We need to continue this work until the end of the outbreak, to keep the capacity in place to rapidly respond to flare-ups, to keep supporting survivors after the outbreak, and to transition the capacities built in this response toward building a stronger health system.

But to be very frank, right now the world risks dropping the baton at the finish line. WHO faces an immediate US $20 million funding gap. If no new resources are received, we will run out of money before the end of the outbreak.

We appreciate the generosity of donors who have supported the response since August 2018. Now we need to get over the finish line. WHO is calling on the international community to help us end this outbreak, and keep our promises to communities to build a stronger health system.

If we are forced to scale back operations because of a lack of funds, and then a new case emerges, we might not have the people and resources on the ground that we need to shut down transmission quickly. Just a single case could re-ignite the epidemic.

That would be a tragedy. An avoidable tragedy.

It is important that the global community doesn’t only focus efforts when there is an immediate threat, then walk away when the threat subsides.

The health system has to be strong to stop much more than Ebola. It has to stop malaria, measles, cholera, and now COVID-19.

There is a lot more work to do.

Thank you.

Read More
https://www.who.int/news-room/detail/06-03-2020-end-in-sight-but-flare-ups-likely-in-the-ebola-outbreak-in-the-democratic-republic-of-the-congo

Views: 0
March 7, 2020
Global gathering of ministers determines road safety agenda to 2030

The 3rd Global Ministerial Conference on Road Safety convened 1700 delegates from around 140 countries, including more than 70 ministers and vice-ministers and heads of international agencies, civil society organizations, foundations and private companies. Hosted at the request of the UN General Assembly by the Government of Sweden in collaboration with WHO, the theme was “Achieving Global Goals 2030”, highlighting the connections between road safety and achievement of other Sustainable Development Goal targets.

Through its 6 high-level panels and 18 parallel sessions, the Ministerial Conference addressed a range of topics, from building effective leadership for road safety to promoting sustainable cities and communities, mitigating climate change through road safety, and ensuring the safety of pedestrians and cyclists. The gathering was instrumental in reviewing progress in the Decade of Action for Road Safety 2011-2020 and defining ways to accelerate action on proven strategies to save lives. Among many pre-events, the 2nd World Youth Assembly for Road Safety hosted by YOURS: Youth for Road Safety and co-hosted by WHO, brought 200 young leaders together proclaiming “Enough is enough!” and claiming their space at the decision-making table for sustainable mobility.

The Ministerial Conference culminated in the forward-looking “Stockholm Declaration”, which calls for a new global target to reduce road traffic deaths and injuries by 50% by 2030. In addition, it invites strengthened efforts on activities in all five pillars of the Global Plan for the Decade of Action: better road safety management; safer roads, vehicles and people; and enhanced post-crash care. It also calls for speeding up the shift to safe, affordable, accessible and sustainable modes of transport like walking, cycling and public transport. WHO is asked to continue to produce the series of global status reports, as a means of monitoring progress towards achievement of the 12 Global Road Safety Performance Targets.

Today, around 1.35 million people lose their lives on the world’s roads every year, and as many as 50 million are injured. More than one quarter of those killed and injured are pedestrians and cyclists. Road traffic injuries are now the leading cause of death for children and young adults aged 5-29 years. Given the enormous human suffering and major economic losses for families and societies, road traffic deaths remain an unacceptable price to pay for mobility.

Read More
https://www.who.int/news-room/detail/20-02-2020-global-gathering-of-ministers-determines-road-safety-agenda-to-2030

Views: 0

March 5, 2020
High energy Li-Ion battery is safer for electric vehicles

A lithium-ion battery that is safe, has high power and can last for 1 million miles has been developed by a team in Penn State’s Battery and Energy Storage Technology (BEST) Center.

Read More

Views: 0

March 4, 2020
Potassium metal battery emerges as a rival to lithium-ion technology

From cell phones, to solar power, to electric cars, humanity is increasingly dependent on batteries. As demand for safe, efficient, and powerful energy storage continues to rise, so too does the call for promising alternatives to rechargeable lithium-ion batteries, which have been the dominant technology in this space.

Read More

Views: 0

March 2, 2020
WHO steps up action to improve access to safe blood
The World Health Organization’s new action plan to speed up universal access to safe blood and blood products pulls together existing recommendations and recommends new improved ways of working. It’s the start of a four-year collaborative effort to improve blood transfusion and blood-based therapies in all countries.

Safe blood saves lives in all sorts of circumstances, not least in emergency and epidemic settings. Blood transfusion and blood products are critical for birth delivery for both the mother and baby; the survival and quality of life of patients suffering from life-threatening conditions such as haemophilia, thalassemia, immune deficiency and cancer; treating severe injuries and carrying out medical and surgical procedures.

But progress in blood safety and availability has been slow in many parts of the world, placing patients’ safety at risk and putting undue pressure on health workers. Progress is also mostly restricted to developed countries. Out of the approximate 118 million blood donations collected globally, 42% are collected in high-income countries, home to 16 % of the world’s population. And one out of four low-income countries do not test all donated blood, while 54% of countries do not have surveillance systems to securitise the supply chain from blood donor to patient.

Challenges include: slow implementation of national blood policies and weak blood regulatory systems; insufficient number of voluntary blood donors (who are considered the safest donors); poor quality management of screening tests, blood grouping and compatibility testing; inappropriate clinical use of blood; insufficient national funding for blood safety.

To address these, WHO has set out six key objectives for all countries and in particular those with weak blood systems:
- appropriately structured, well-coordinated and sustainably resourced national blood systems;
- regulatory capacity to ensure the quality and safety of blood;
- functioning and efficiently managed blood services;
- effective implementation of patient blood management to optimize transfusion practices;
- effective surveillance, haemovigilance and pharmacovigilance, supported by comprehensive and accurate data collection systems;
- partnerships, collaboration and information exchange to achieve key priorities and jointly address challenges and emerging threats at global, regional and national levels.
The Organization looks forward to working with partners worldwide to implement the plan, improve blood supply particularly in the low and middle-income countries where this is so urgently needed, and save lives. The plan will run from 2020-2024.

Read More
https://www.who.int/news-room/detail/26-02-2020-who-steps-up-action-to-improve-access-to-safe-blood

Views: 0
February 27, 2020
WHO Action framework to advance universal access to safe, effective and quality assured blood products 2020 -2023

In response to calls for action, WHO has provided guidelines, physical standards, training and technical support to improve blood product quality, safety and availability in WHO regions and in countries. Despite these actions, progress in blood availability and safety under effective regulation has been slow in many parts of the world.

For that reason, the WHO Action framework for blood products 2020-2023, proposes a renewed effort to scale up programme implementation to improve global adequacy of blood donation, and universal access to quality and safe blood and blood components for transfusion, and plasma derived medicinal products.

The Action Framework provides strategic direction to WHO’s work for the years 2020-2023. It identifies six strategic objectives: appropriately structured, well-coordinated and sustainably resourced national blood systems; regulatory capacity to ensure the quality and safety of blood; functioning and efficiently managed blood services; effective implementation of patient blood management to optimize transfusion practices, effective surveillance, haemovigilance and pharmacovigilance, supported by comprehensive and accurate data collection systems; and partnerships, collaboration and information exchange to achieve key priorities and jointly address challenges and emerging threats at global, regional and national levels.

The Action Framework will improve coordination and collaboration at all levels of WHO. The document will promote and strengthen new and existing partnerships, as areas for collaborative action are clearly identified. Moreover, it demonstrates the need for support to WHO (including sustainable funding) to coordinate the implementation of this ambitious plan. As a result, the Action Framework for blood products will allow WHO to more effectively carry out its mandate on blood, and to increase the impact of WHO activities to strengthen blood systems and blood regulation in countries and regions and eventually to ensure universal access to blood products worldwide.

Read More
https://www.who.int/news-room/detail/19-02-2020-who-action-framework-to-advance-universal-access-to-safe-effective-and-quality-assured-blood-products-2020–2023

Views: 0

February 27, 2020
Immunization is the best protection against tick-borne encephalitis

In a new position paper, published in the Weekly
Epidemiological Record today, WHO recommends vaccination against
tick-borne encephalitis in people of all ages where the disease is
highly endemic. Where the prevaccination incidence of the disease is
moderate or low or is limited to particular geographical locations or
certain outdoor activities, immunization should target individuals in
the most severely affected groups. People travelling from non-endemic
areas to endemic areas should be offered vaccination if their visits
will include extensive outdoor activities.

Since the incidence of tick-borne encephalitis may vary
considerably between and even within geographical regions, public
immunization strategies should be based on risk assessments conducted at
country, regional or district level, and should be appropriate to the
local endemic situation.

Immunization offers the most effective protection against
tick-borne encephalitis. Currently, there are four widely used vaccines
of assured quality: FSME-Immun and Encepur, manufactured in Austria and
Germany respectively, and TBE-Moscow and EnceVir, manufactured in the
Russian Federation. The four vaccines are considered to be safe and
efficacious.

Tick-borne encephalitis virus is an important cause of viral
infections of the central nervous system in eastern, central and
northern European countries, and in northern China, Mongolia, and the
Russian Federation.

Approximately 10 000–12 000 clinical cases of tick-borne
encephalitis are reported each year, but this figure is believed to be
significantly lower than the actual total. Most infections with the
virus result from tick bites acquired during outdoor activities in
forested areas.

Read More
https://www.who.int/news-room/detail/19-02-2020-immunization-is-the-best-protection-against-tick-borne-encephalitis

Views: 0

February 27, 2020
Four countries in the African region license vaccine in milestone for Ebola prevention

The Democratic Republic of the Congo (DRC), Burundi, Ghana and Zambia have licensed an Ebola vaccine, just 90 days after World Health Organization (WHO) prequalification. Registration of the vaccine is expected in additional countries in the coming weeks.

The licensing of the vaccine means that the manufacturer can stockpile and widely distribute this vaccine to African countries at risk of Ebola virus disease outbreaks. Once licensed doses are available, use of the vaccine will not require clinical trial or other research protocols.

“The approval of the Ebola vaccine by these countries is another milestone in the fight against this unforgiving disease,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “Africa has rallied to cement hard-fought progress to keep its people safe from Ebola.”

WHO accelerated the licensing and roll-out of the Ebola vaccine by certifying that it met the organization’s standards for quality, safety and efficacy in its fastest vaccine prequalification process ever, announced in November 2019.

The speed with which this has been achieved has been made possible by a different approach, where national licensing procedures were done in parallel based on one single scientific review process. Usually, these process are done one by one, which can take years. The process was led by WHO with the participation of the African Vaccine Regulatory Forum (an African network of national regulatory authorities and ethics committees), the European Medicines Agency, and Merck.

“The rapid approval of the Ebola vaccine by countries in the Africa Region helps ensure this critical prevention tool will be available when and where it is needed most,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “This kind of collaboration and innovation is a model for other health priorities.”

The injectable Ebola vaccine, Ervebo, is manufactured by Merck (known as MSD outside the US and Canada). Preliminary study results have shown a 97.5% vaccine efficacy. Data also suggests that vaccinating people who are already infected reduces their chances of dying.

In response to the ongoing Ebola outbreak in the DRC, over 290 000 people have been vaccinated under compassionate use protocols. Once licensed doses are available, use of the vaccine in DRC will no longer require these protocols

Read More
https://www.who.int/news-room/detail/14-02-2020-four-countries-in-the-african-region-license-vaccine-in-milestone-for-ebola-prevention

Views: 0

February 27, 2020